Deadly Harvest: The Intimate Relationship Between Our Heath and Our Food (68 page)

349
Comstock, G.W., A.E.
Burke, S.C. Hoffman, et al.
“Serum Concentrations of Alpha Tocopherol, Beta Carotene, and Retinol Preceding the Diagnosis of Rheumatoid Arthritis and Systemic Lupus Erythematosus.”
Ann Rheum Dis
56:5 (1997): 323–325.

350
Linos, A., V.G.
Kaklamani, E. Kaklamani, et al.
“Dietary Factors in Relation to Rheumatoid Arthritis: A Role for Olive Oil and Cooked Vegetables?”
Am J Clin Nutr
70:6 (1999): 1077–1082.

351
Hafstrom, I., B.
Ringertz, A. Spangberg A, et al.
“A Vegan Diet Free of Gluten Improves the Signs and Symptoms of Rheumatoid Arthritis: The Effects on Arthritis Correlate with a Reduction in Antibodies to Food Antigens.”
Rheumatology (Oxford)
40:10 (2001): 1175–1179.

Carli, P., A.
Chagnon, J.R. Harle, et al.
“Inflammatory Rheumatism and Celiac Disease in Adults: Coincidence or Pathogenic Relationship?”
Presse Med
24:13 (1995): 606–610.

352
Ratner, D., E.
Eshel, and K. Vigder.
“Juvenile Rheumatoid Arthritis and Milk Allergy.”
J R Soc Med
78:5 (1985): 410–413.

353
Molleson, T. “Eloquent Bones of Abu Hureyra.”
Sci Am
271:2 (1994): 70–75.

354
Kurtz, S., F.
Mowat, K. Ong, et al.
“Prevalence of Primary and Revision Total Hip and Knee Arthroplasty in the United States from 1990 Through 2002.”
J Bone Joint Surg Am
87:7 (2005): 1487–1497.

355
Curtis, C.L., S.G.
Rees, J. Cramp,
et al. “Effects of n-3 Fatty Acids on Cartilage Metabolism.”
Proc Nutr Soc
61:3 (2002): 381–389.

James, M.J., S.M.
Proudman, and L.G. Cleland.
“Dietary n-3 Fats as Adjunctive Therapy in a Prototypic Inflammatory Disease: Issues and Obstacles for Use in Rheumatoid Arthritis.”
Prostaglandins Leukot Essent Fatty Acids
68:6 (2003): 399–405.

356
Wucherpfennig, K.W., and J.L.
Strominger.
“Molecular Mimicry in T Cell–mediated Autoimmunity: Viral Peptides Activate Human T Cell Clones Specific for Myelin Basic Protein.”
Cell
80:5 (1995): 695–705.

357
Matheson, N.A. “Letter: Multiple Sclerosis and Diet.”
Lancet
2:7884 (1974): 831.

358
Hartung, H.P., and P.
Rieckmann.
“Pathogenesis of Immune-mediated Demyelination in the CNS.”
J Neural Transm Suppl
50 (1997): 173–181.

359
Lange, L.S., and M.
Shiner.
“Small-bowel Abnormalities in Multiple Sclerosis.”
Lancet
2:7999 (1976): 1319–1322.

360
Bernsohn, J., and L.M.
Stephanides.
“Aetiology of Multiple Sclerosis.”
Nature
215:103 (1967): 821–823. Kishimoto, Y., N.S.
Radin, W.W. Tourtellotte, et al.
“Gangliosides and Glycerophospholipids in Multiple Sclerosis White Matter.”
Arch Neurol
16:1 (1967): 41–54.

361
Kromann, N., and A. Green. “Epidemiological Studies in the Upernavik District, Greenland. Incidence of Some Chronic Diseases 1950–1974.”
Acta Med Scand
208 (1980): 401–406.

362
Simopoulos, A.P. “Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases.”
J Am Coll Nutr
21:6 (2002): 495–505.

363
Ghadirian, P., R. Morisset, and M. Jain. “Nutritional Factors in the Aetiology of Multiple Sclerosis: A Case-control Study in Montreal, Canada.”
Intl J Epidemiol
27:5 (1998): 845–852. Nordvik, I., K.M. Myhr, H. Nyland, et al.
“Effect of Dietary Advice and n-3 Supplementation in Newly Diagnosed MS Patients.”
Acta Neurol Scand
102:3 (2000): 143–149.

Cendrowski, W. “Multiple Sclerosis and MaxEPA.”
Br J Clin Pract
40:9 (1986): 365–367.

364
Munger, K.L., S.M.
Zhang, E. O’Reilly, et al.
“Vitamin D Intake and Incidence of Multiple Sclerosis.”
Neurology
62:1 (2004): 60–65.

365
Cantorna, M.T. “Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease?”
Proc Soc Exp Biol Med
223:3 (2000): 230–233.

366
World Health Organization.
Mental Health: New Understanding, New Hope.
The World Health Report 2001.
Geneva: World Health Organization, 2001.

367
World Health Organization.
Mental Health: New Understanding, New Hope.
The World Health Report 2001.
Geneva: World Health Organization, 2001.

368
Bennet, C.N., and D.F. Horrobin. “Gene Targets Related to Phospholipid and Fatty Acid Metabolism in Schizophrenia and Other Psychiatric Disorders: An Update.”
Prostaglandins Leukot Essent Fatty Acids
63:1–2 (2000):
47–59
.

Horrobin, David, and Crispin N. Bennett. “The Phospholipid Concept of Psychiatric Disorders.” In Peet, M., I. Glen, and D. Horrobin (eds.).
Phospholipid Spectrum Disorders in Psychiatry and Neurology
, 2nd edition. Carnforth: Marius Press, 2003.

369
Mann, J., and A.S. Truswell.
Essentials of Human Nutrition
, 2nd edition.
Oxford: Oxford University Press, 2002

370
Chafetz, M.D.
Nutrition and Neurotransmitters: The Nutrient Bases of Behaviour
.
Englewood Cliffs, NJ: Prentice Hall, 1990.

371
Casadesus, G. “Caloric Restriction Versus a Diet High in Antioxidants: Are They Equipotent in Altering or Reversing the Course of Aging?” In Mattson, Mark P. (ed.).
Diet-Brain Connections: Impact on Memory, Mood, Aging and Disease
. Dordrecht: Kluwer Academic Publishers, 2002.

372
Crawford, M., and D. Marsh.
The Driving Force: Food, Evolution and the Future
.
New York: Harper & Row, 1989.

373
Benton, D. “Diet and Mood.” In Mattson, Mark P. (ed.).
Diet-Brain Connections: Impact on Memory, Mood, Aging and Disease
. Dordrecht: Kluwer Academic Publishers, 2002.

374
Richardson, A.J., and B.K. Puri. “The Potential Role of Fatty Acids in Attention-Deficit/Hyperactivity Disorder.”
Prostaglandins Leukot Essent Fatty Acids
63:1–2 (2000):
79–87
.

375
Hull, M., K. Lieb, and B.L. Fiebich. “Pathways of Inflammatory Activation in Alzheimer’s Disease: Potential Targets for Disease-modifying Drugs.”
Curr Med Chem
9:1 (2002): 83–88.

376
Hendrie, H.C., B.O.
Osuntokun, K.S. Hall,
et al. “Prevalence of Alzheimer’s Disease and Dementia in Two Communities: Nigerian Africans and African Americans.”
Am J Psychiatry
152:10 (1995):
1485–1492
. White, L., H.
Petrovitch, G.W. Ross,
et al. “Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study.”
JAMA
276:12 (1996):
955–960
.

377
Grant, W.B. “Dietary Links to Alzheimer’s Disease.”
Alzheimer’s Dis Rev
2 (1997): 42–55. Kalmijn, S. “Dietary Fatty Acids and Cognitive Function.” In Mattson, Mark P. (ed.).
Diet-Brain Connections: Impact on Memory, Mood, Aging and Disease
. Dordrecht: Kluwer Academic Publishers, 2002.

Kalmijn, S., L.J.
Launer, A. Ott,
et al. “Dietary Fat Intake and the Risk of Incident Dementia in the Rotterdam Study.”
Ann Neurol
42:5 (1997):
776–782
.

Morris, M.C., D.A.
Evans, J.L. Bienias,
et al.
“Dietary Fats and the Risk of Incident Alzheimer Disease.”
Arch Neurol
60:2 (2003):
194200
.

378
Kalmijn, S. “Dietary Fatty Acids and Cognitive Function.” In Mattson, Mark P. (ed.).
Diet-Brain Connections: Impact on Memory, Mood, Aging and Disease
. Dordrecht: Kluwer Academic Publishers, 2002.

Conquer, J.A., M.C.
Tierney, J. Zecevic,
et al.
“Fatty Acid Analysis of Blood Plasma of Patients with Alzheimer’s Disease, Other Types of Dementia, and Cognitive Impairment.”
Lipids
35:12 (2000):
1305–1312
.

Tully, A.M., H.M.
Roche, R. Doyle,
et al. “Low Serum Cholesteryl Ester-Docosahexaenoic Acid Levels in Alzheimer’s Disease: A Case-Control Study.”
Br J Nutr
89:4 (2003):
483–489
.

Soderberg, M., C.
Edlund, K. Kristensson, and G. Dallner.
“Fatty Acid Composition of Brain Phospholipids in Aging and in Alzheimer’s Disease.”
Lipids
26:6 (1991):
421–425
.

379
Arvanitakis, Z., R.S.
Wilson, J.L. Bienias, et al.
“Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function.”
Arch Neurol
61:5 (2004): 661–666.

380
Convit, A., O.T.
Wolf, C. Tarshish, and M.J. de Leon.
“Reduced Glucose Tolerance is Associated with Poor Memory Performance and Hippocampal Atrophy Among Normal Elderly.”
Proc Natl Acad Sci USA
100:4 (2003): 2019–2022.

381
Gustafson, D., L. Lissner, C. Bengtsson, et al. “A 24-year Follow-up of Body Mass Index and Cerebral Atrophy.”
Neurology
63 (2004): 1876–1881.

Whitmer, R.A., E.P.
Gunderson, E. Barrett-Connor, et al.
“Obesity in Middle Age and Future Risk of Dementia: A 27-year Longitudinal Population-based Study.”
Br Med J
330:7504 (2005): 1360.